Logo Logo
Hilfe
Hilfe
Switch Language to English

Shelke, Vishwadeep; Kale, Ajinath; Anders, Hans-Joachim und Gaikwad, Anil Bhanudas (2022): Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease. In: Molecular and Cellular Biochemistry, Bd. 478, Nr. 9: S. 1987-1998

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Kidney disease is the 6th fastest-growing cause of death and a serious global health concern that urges effective therapeutic options. The inflammatory response is an initial reaction from immune and parenchymal cells in kidney diseases. Toll-like receptors (TLR) 2 and 4 are highly expressed by various kidney cells and respond to 'signaling danger' proteins, such as high mobility group box binding protein 1 (HMGB1) and prompt the progression of kidney disease by releasing inflammatory mediators. Burgeoning reports suggest that both SGLT2 and ER stress elevates TLR2/4 signaling via different axis. Moreover, SGLT2 signaling aggravates inflammation under the disease condition by promoting the NLR family pyrin domain-containing three inflammasomes and ER stress. Intriguingly, TLR2/4 downstream adaptors activate ER stress regulators. The above-discussed interactions imply that TLR2/4 does more than immune response during kidney disease. Here, we discuss in detail evidence of the roles and regulation of TLR2/4 in the context of a relationship between ER stress and SGLT2. Also, we highlighted different preclinical studies of SGLT2 inhibitors against TLR2/4 signaling in various kidney diseases. Moreover, we discuss the observational and interventional evidence about the relation between TLR2/4, ER stress, and SGLT2, which may represent the TLR2/4 as a potential therapeutic target for kidney disease.

Dokument bearbeiten Dokument bearbeiten